Who owns Pulse Biosciences?
- Ticker: PLSE
- CUSIP Number: 74587b101
Tip: Access positions for across all investors
Analyze quarterly positions in Pulse Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pulse Biosciences stock
Who bought or sold Pulse Biosciences this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bank of America Corporation | 801k | $9.8M | 1% | Dec 2023 |
|
| Vanguard Group | 658k | $8.1M | 93% | Dec 2023 |
|
| Griffin Asset Management | 300k | $2.6M | 16% | Mar 2024 |
|
| Spotlight Asset Group | 72k | $291k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 44k | $541k | -26% | Dec 2023 |
|
| Charles Schwab Investment Management | 44k | $535k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 41k | $360k | -11% | Mar 2024 |
|
| Citadel Advisors | 41k | $497k | 60% | Dec 2023 |
|
| Jane Street | 34k | $411k | 100% | Dec 2023 |
|
| Westside Investment Management | 32k | $280k | -6% | Mar 2024 |
|
| CWM Advisors | 31k | $383k | 100% | Dec 2023 |
|
| Simplex Trading | 31k | $265k | -11% | Mar 2024 |
|
| Tiaa Trust, National Association | 27k | $334k | 0% | Dec 2023 |
|
| Marshall Wace | 27k | $325k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 23k | $286k | 32% | Dec 2023 |
|
| Barclays | 22k | $271k | 641% | Dec 2023 |
|
| Wealthtrust Axiom | 22k | $263k | 0% | Dec 2023 |
|
| Pnc Financial Services | 20k | $242k | 100% | Dec 2023 |
|
| UBS Group | 19k | $228k | 107% | Dec 2023 |
|
| Royal Bank of Canada | 15k | $182k | 124% | Dec 2023 |
|
| Wells Fargo & Company | 13k | $163k | -11% | Dec 2023 |
|
| Jpmorgan Chase & Co | 12k | $142k | 11% | Dec 2023 |
|
| Mirae Asset Global Investments | 11k | $129k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 9.1k | $111k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 8.2k | $101k | 0% | Dec 2023 |
|
| American International | 8.0k | $98k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 7.7k | $94k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 4.6k | $57k | -7% | Dec 2023 |
|
| LM Advisors | 2.4k | $30k | 100% | Dec 2023 |
|
| Citigroup | 2.3k | $28k | 33114% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 2.0k | $22k | 0% | Dec 2023 |
|
| Legal & General Group | 1.4k | $18k | -7% | Dec 2023 |
|
| Russell Investments | 1.4k | $17k | 100% | Dec 2023 |
|
| Summit Investment Advisors | 1.3k | $16k | 0% | Dec 2023 |
|
| Osterweis Capital Management | 1.0k | $12k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 988.00 | $12k | 100% | Dec 2023 |
|
| Amalgamated Bank | 545.00 | $5.0k | -67% | Mar 2024 |
|
| Steward Partners Investment Advisory | 178.00 | $2.2k | 0% | Dec 2023 |
|
| Lindbrook Capital | 156.00 | $1.4k | 100% | Mar 2024 |
|
| CGC Financial Services | 133.00 | $1.2k | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Pulse Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Sep 2023 | 48k | $192k |
| Levin Capital Strategies | Sep 2023 | 20k | $80k |
| Squarepoint Ops | Sep 2023 | 20k | $79k |
| Robert Bender & Associates | Dec 2023 | 10k | $126k |